HU Guo-xin
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- RNA modifications and cancer
- Circular RNAs in diseases
- RNA Research and Splicing
Papers in
-
- Inflammation biomarkers and pathways 2
- Immune Response and Inflammation 2
-
- Pharmacogenetics and Drug Metabolism 1
- Co-authors
- Jin-fang Zhang (1 shared paper)Li Zhang (1 shared paper)David Chi‐Cheong Wan (1 shared paper)Mary Miu Yee Waye (1 shared paper)Yan Wang (1 shared paper)Jinming Peng (1 shared paper)Zhiqiang Zhang (1 shared paper)Barry R. Zirkin (1 shared paper)
In The Last Decade
HU Guo-xin
12 papers receiving 640 citations
HU Guo-xin's Hit Papers
Peers
Comparison fields: 5 of 70
- Cancer Research 448
- Molecular Biology 372
- Environmental Chemistry 42
- Health, Toxicology and Mutagenesis 29
- Epidemiology 49
Countries citing papers authored by HU Guo-xin
This map shows the geographic impact of HU Guo-xin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by HU Guo-xin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites HU Guo-xin more than expected).
Fields of papers citing papers by HU Guo-xin
This network shows the impact of papers produced by HU Guo-xin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by HU Guo-xin. The network helps show where HU Guo-xin may publish in the future.
Co-authors
The 25 scholars most cited alongside HU Guo-xin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | The lncRNA H19 promotes epithelial to mesenchymal transition by functioning as miRNA sponges in colorectal cancer Hit paper breakdown → | 2015 | 502 |
| 2 | 2010 | 54 | |
| 3 | 2019 | 33 | |
| 4 | 2020 | 15 | |
| 5 | 2021 | 14 | |
| 6 | 2015 | 11 | |
| 7 | 2022 | 5 | |
| 8 | 2019 | 5 | |
| 9 | 2002 | 3 | |
| 10 | Functional assessment of CYP3A4 allelic variants on lidocaine metabolism in vitro | 2017 | 2 |
| 11 | Toxicokinetics of methoxychlor and its metabolite 2,2-bis-(p-hydroxyphenyl)-1,1,1-trichloroethane in rats | 2011 | 1 |
| 12 | Determination of active metabolite of oxcarbazepine by RP-HPLC and study of its pharmacokinetics in Chinese healthy volunteers | 2005 | 1 |
| 13 | 2016 | 0 | |
| 14 | 2024 | 0 |
About HU Guo-xin
HU Guo-xin is a scholar working on Immunology, Pharmacology, Epidemiology, Clinical Biochemistry and Physiology, having authored 14 papers that have together received 646 indexed citations. Recurring topics across this work include Inflammation biomarkers and pathways (2 papers), Advanced Glycation End Products research (2 papers), Immune Response and Inflammation (2 papers), Pharmacogenetics and Drug Metabolism (1 paper), Nitric Oxide and Endothelin Effects (1 paper), Epilepsy research and treatment (1 paper), Mycobacterium research and diagnosis (1 paper) and Synthesis and pharmacology of benzodiazepine derivatives (1 paper). The work is most often cited by research in Cancer Research (448 citations), Molecular Biology (372 citations), Environmental Chemistry (42 citations), Health, Toxicology and Mutagenesis (29 citations) and Epidemiology (49 citations). HU Guo-xin has collaborated with scholars based in China, Hong Kong and Australia. Frequent co-authors include Jin-fang Zhang, Li Zhang, David Chi‐Cheong Wan, Mary Miu Yee Waye, Yan Wang, Jinming Peng, Zhiqiang Zhang, Barry R. Zirkin, Benson T. Akingbemi and Jian Liu. Their work appears in journals such as Chemico-Biological Interactions, Oncotarget, Peptides, Pharmacology and Medical Science Monitor.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.